This inventor holds 1 USPTO granted patent. Top assignee: Osaka Industrial Promotion Organization. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Yoshito Takeda: Innovator in Osteoporosis and Chronic Obstructive Pulmonary Disease Research
Introduction
Yoshito Takeda is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of model animals for studying osteoporosis and chronic obstructive pulmonary disease (COPD). His innovative work aims to enhance the understanding and treatment of these conditions.
Latest Patents
Takeda holds a patent for a "CD9/CD81 double-deficient non-human animal." This invention provides a non-human animal model that effectively exhibits the pathological conditions associated with low-turnover osteoporosis and COPD. The model is designed for screening therapeutic agents aimed at treating osteoporosis and COPD. The patent details a non-human animal in which genes coding for CD9 and CD81 are deficient in somatic cells. It also outlines methods for using this animal as a model for osteoporosis and COPD, including steps to measure osteogenesis inhibition and phenotypic similarities to COPD.
Career Highlights
Yoshito Takeda is affiliated with the Osaka Industrial Promotion Organization, where he continues to advance his research. His work has garnered attention for its potential to improve therapeutic strategies for debilitating diseases.
Collaborations
Takeda collaborates with notable colleagues, including Eisuke Mekada and Kenji Miyado. Their combined expertise contributes to the innovative research being conducted in the field.
Conclusion
Yoshito Takeda's contributions to biomedical research, particularly through his patent on a novel animal model, highlight his role as an influential inventor. His work promises to pave the way for new therapeutic approaches to osteoporosis and chronic obstructive pulmonary disease.